google-site-verification: googlec7193c3de77668c9.html

NHS patients in England can have life-saving heart drug tafamidis

About 1,500 people in England with ATTR-CM could now be eligible for the treatment.

This rare heart condition typically starts to show in adulthood and gets worse over time as the heart tissue thickens and stiffens.

Its symptoms include:

  • shortness of breath

  • palpitations and abnormal heart rhythms

  • ankle swelling, fatigue, fainting and chest pain

Ultimately, it can cause heart failure.

Prof Simon Ray, national clinical director for heart disease at NHS England, said: ”A first of its kind, tafamidis will give those living with this rare progressive condition new hope.

“This pioneering drug is just one example of the NHS delivering on its commitment to ensure patients across the country have access to the latest and most effective treatments to help significantly improve their quality of life.”

The list price for a packet of 30 capsules of the drug is about £10,000, but Pfizer has a commercial agreement for NHS use which will be less, although the cost has not been made public.


Source link

Views: 1

See also  Where are we and where are we going?

Check Also

Resident doctors to strike for 16th time over pay

British Medical Association resident doctor members in England announce new strike for four days from …

Strength exercises improve young people's hip pain

[ Physiotherapist-led strength exercises improve hip pain in young people suffering hip joint impingements, new …

Why you wake up so tired after vivid dreams

[ Some mornings when you wake up, your head is fuzzy, your body is heavy, …

Leave a Reply

Available for Amazon Prime
Nordicnodes | professional saas tools for everyone.